Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03192839
Other study ID # 6039
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2017
Est. completion date August 30, 2018

Study information

Verified date May 2019
Source Mead Johnson Nutrition
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial will evaluate the effects of giving supplements of PUFA to premature infants.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date August 30, 2018
Est. primary completion date July 9, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 3 Days
Eligibility Inclusion Criteria:

- Very low birth weight infants weighing less than 1500 grams

- Consent signed within 72 hours of life

Exclusion Criteria:

- Infants with know metabolic disorder

- Infants with known congenital GI anomaly

- Infants who are deemed to be inappropriate for enrollment per attending neonatologist

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Low dose PUFA
Low dose PUFA
High dose PUFA
High dose PUFA
Placebo
Placebo

Locations

Country Name City State
United States Rush University Medical Center Chicago Illinois
United States North Shore University Health System Evanston Illinois

Sponsors (2)

Lead Sponsor Collaborator
Mead Johnson Nutrition North Shore Research Institue

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Red Blood Cell polyunsaturated fatty acids (PUFA) levels 2 weeks of age
Secondary Red Blood Cell PUFA levels 8 weeks of age
Secondary Feeding tolerance Full enteral feed of 120 kcal/kg/day 8 weeks
Secondary Incidence of necrotizing enterocolitis 8 weeks
Secondary Incidence of bronchopulmonary dysplasia 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03670732 - CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure N/A
Completed NCT05322161 - Yoga in the NICU for Parents Study N/A
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Recruiting NCT04911452 - Creating a Calmer NICU: Optimizing Growth and Brain Development in Preterm Infants N/A
Recruiting NCT02901652 - NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome N/A
Completed NCT02148965 - Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial N/A
Terminated NCT02032511 - Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP) N/A
Completed NCT02273843 - A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis Phase 1
Completed NCT01721629 - Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants N/A
Terminated NCT01819532 - Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks N/A
Completed NCT00951860 - Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort N/A
Completed NCT01523769 - Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants N/A
Completed NCT01478711 - Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants N/A
Completed NCT00787124 - Transfusions and Nitric Oxide Level in Preterm Infants
Completed NCT00749008 - Study of Generalized Movements for Early Prediction of Cerebral Palsy N/A
Completed NCT00527956 - Facilitation and Barriers to Breastfeeding in the NICU N/A
Terminated NCT00486395 - Will CPAP Reduce Length Of Respiratory Support In Premature Infants? Phase 3
Terminated NCT01208493 - Dietary Protein in the Very-low-birth-weight Infant N/A
Completed NCT03372590 - NEO Rehab for Infants at Risk of Cerebral Palsy N/A
Completed NCT00033917 - Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial Phase 3